Pharmaceuticals

Precision Medicine Market Trends 2025–2029: Forecasts for Key Growth Segments

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Precision Medicine Market Expected To Expand Between 2025 And 2029?

The precision medicine market has experienced substantial growth in recent years. Its size is projected to expand from $80.15 billion in 2024 to $87.91 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.7%. Historically, this expansion has been driven by factors such as an increase in cancer prevalence, a rising incidence of mental health disorders, a greater prevalence of respiratory diseases, increasing funding, a growing geriatric population, higher pharmaceutical R&D expenditure, and elevated healthcare expenditure.

The precision medicine market is anticipated to experience robust expansion over the coming years. It is projected to reach $126.14 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.4%. Factors contributing to this growth during the forecast period include a rising elderly population, a growing incidence of cancer, the significant potential of developing economies, the appearance of new pathogenic infestations, increased expenditure on research and development, and a general rise in healthcare spending. Key trends anticipated for the forecast period encompass the integration of artificial intelligence technologies to enhance competitiveness, the provision of diagnostic tools and tailored treatments for immune-mediated conditions, heightened investment in research and development initiatives, and the establishment of alliances and partnerships with technology and healthcare organizations to strengthen product offerings.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp

Which Drivers Are Supporting Growth Of The Precision Medicine Market?

The expanding incidence of cancer is anticipated to propel the precision medicine market’s expansion. Globally, cancer stands as a leading cause of mortality, with approximately one in five people experiencing a cancer diagnosis during their lifetime. In oncology, precision medicine involves examining tumor DNA to identify mutations or other genetic irregularities responsible for the disease. This approach allows medical professionals to select treatments for individual patients that specifically target the identified tumor DNA changes. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency responsible for international public health, projections indicate over 35 million new cancer cases by 2050, signifying a 77% rise from the approximately 20 million cases recorded in 2022. Consequently, the increasing occurrence of cancer stimulates the expansion of the precision medicine market.

What Are The Primary Types Of Segments Analyzed In The Precision Medicine Market?

The precision medicine market covered in this report is segmented –

1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology

2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.

3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others

Subsegments:

1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining

2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis

3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing

4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials

5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests

6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology

Which Ongoing Trends Are Expected To Shape The Precision Medicine Market Outlook?

The growing incidence of partnerships and acquisitions among precision medicine firms allows them to broaden their scope to include both oncology and non-oncology sectors. Precision medicine is continuously undergoing research and development in novel areas, and through collaboration and partnership, companies can enhance their capabilities and approaches. For instance, in September 2022, GSK plc, a UK-based pharmaceutical company, deepened its collaboration with Tempus, a US-based precision medicine company. This three-year partnership aims to refine clinical trial designs, expedite patient enrollment, and identify new drug targets by leveraging Tempus’ AI-enabled platform and extensive de-identified patient data. Building on their previous work, this collaboration is expected to boost GSK’s research and development strengths, particularly in the field of oncology.

Who Are The Prominent Global Companies Shaping The Precision Medicine Market?

Major companies operating in the precision medicine market include Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

What Are The Key Regional Factors Influencing The Precision Medicine Market Growth?

North America was the largest region in the precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Precision Medicine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=5301&type=smp

Browse Through More Reports Similar to the Global Precision Medicine Market 2025, By The Business Research Company

Electronic And Precision Equipment Repair And Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electronic-and-precision-equipment-repair-and-maintenance-global-market-report

Research Antibodie And Reagent Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

Catalyst Fertilizer Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/catalyst-fertilizer-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795